Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search
Abstract
The aim of review. To present algorithm of stepwise clinical and laboratoric testing of patients with long-term asymptomatic elevation of serum aminotransferase activity.
Key points. According to epidemiologic data, 10–20% of adult population of the developed countries has increased activity of aminotransferases. The majority of such patients present either no health-related complaints at all, or nonspecific symptoms. Data of common clinical examination and routine laboratory and instrumental tests frequently do not allow to determine satisfactory diagnostic hypothesis. The situation is even more complicated by the absence of domestic practical guidelines on management of these patients. Article presents the algorithm of clinical, laboratory and instrumental testing in described clinical situation. The algorithm is based on the analysis of consensus documents, original studies, experts opinions and authors’ experience.
Conclusion. Differential diagnostics at long-term asymptomatic elevation of serum aminotransferase activity should be carried out by step-wise algorithm at which diagnostic search is directed from the most common to more rare possible nosological units.
About the Authors
Yu. A. Tereshchenko
State educational state-funded institution of higher professional education «Voyno-Yasenetsky Krasnoyarsk state medical university» Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Tereshchenko Yury A. – MD, PhD, professor
S. Yu. Tereshchenko
State educational state-funded institution of higher professional education «Scientific research institute of medical problems of the North» Russian Academy of Medical Science, Siberian branch
Russian Federation
Russian Federation
Tereshchenko Sergey Yu – MD, PhD, professor
660022, Krasnoyarsk, Partizana Zhelyeznyaka street, 3G
References
1. Герман Е.Н., Маевская М.В., Люсина Е.О., Ивашкин В.Т. Принципы ведения пациента с бессимптомным повышением активности сывороточных аминотрансфераз (клиническое наблюдение) // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2011. – Т. 21, № 1. – С. 63–68.
2. Green R.M., Flamm S. AGA technical review on the evaluation of liver chemistry tests // Gastroenterology. – 2002. – Vol. 123, N 4. – P. 1367–1384.
3. Minuk G.Y. Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests // Can. J. Gastroenterol. – 1998. – Vol. 12, N 6. – P. 417–421.
4. Oh R.C., Hustead T.R. Causes and evaluation of mildly elevated liver transaminase levels // Am. Fam. Phys. –2011. – Vol. 84, N 9. – P. 1003–1008.
5. Aragon G., Younossi Z.M. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients // Cleveland Clin. J. Med. – 2010. – Vol. 77, N 3. – P. 195–204.
6. Giboney P.T. Mildly elevated liver transaminase levels in the asymptomatic patient // Am. Fam. Phys. – 2005. – Vol. 71, N 6. – P. 1105–1110.
7. Pratt D.S., Kaplan M.M. Evaluation of abnormal liverenzyme results in asymptomatic patients // N. Engl. J. Med. – 2000. – Vol. 342, N 17. – P. 1266–1271.
8. Litin S.C., O’brien J.F., Pruett S. et al. Macroenzyme as a cause of unexplained elevation of aspartate aminotransferase // Mayo Clinic proceedings. Mayo Clinic. – 1987. – Vol. 62, N 8. – P. 681–687.
9. Kaplan M., Keeffe E. What do abnormal liver function test results really mean? // Patient Care Nurse Pract. – 2003. – Vol. 6, N 5. – P. 7–9.
10. Giannini E., Risso D., Botta F. et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease // Arch. Int. Med. – 2003. – Vol. 163, N 2. – P. 218–224.
11. Imperiale T.F., Said A.T., Cummings O.W., Born L.J. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C // Am. J. Gastroenterol. – 2000. – Vol. 95, N 9. – P. 2328–2332.
12. Ioannou G.N., Boyko E.J., Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999–2002 // Am. J. Gastroenterol. – 2006. – Vol. 101, N 1. – P. 76–82.
13. Tsai J., Ford E.S., Li C., Zhao G. Past and current alcohol consumption patter ns and elevations in serum hepatic enzymes among US adults // Addictive behaviors. – 2012. – Vol. 37, N 1. – P. 78–84.
14. Wedemeyer H., Hofmann W.P., Lueth S. et al. ALT screening for chronic liver diseases: scrutinizing the evidence // Z. Gastroenterol. – 2010. – Vol. 48, N 1. – P. 46–55.
15. Papatheodoridis G.V., Goulis J., Christodoulou D. et al. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity // Eur. J. Gastroenterol. Hepatol. – 2007. – Vol. 19, N 4. – P. 281–287.
16. Chen C.H., Huang M.H., Yang J.C. et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan // J. Gastroenterol. Hepatol. – 2007. – Vol. 22, N 9. – P. 1482–1489.
17. Zhang H., He S.M., Sun J. et al. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China // Int. J. Med. Sci. – 2011. – Vol. 8, N 3. – P. 254–262.
18. Daniel S., Ben-Menachem T., Vasudevan G. et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients // Am. J. Gastroenterol. – 1999. – Vol. 94, N 10. – P. 3010–3014.
19. Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology // J. Hepatol. – 2001. – Vol. 35, N 2. – P. 195–199.
20. Ruhl C.E., Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population // Gastroenterology. – 2009. – Vol. 136, N 2. – P. 477–485 e411.
21. Lazo M., Selvin E., Clark J.M. Brief communication: clinical implications of short-term variability in liver function test results // Ann. Int. Med. – 2008. – Vol. 148, N 5. – P. 348–352.
22. Ющук Н.Д., Климова Е.А., Знойко О.О. и др. Протокол диагностики и лечения больных вирусными гепатитами В и С // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2010. – Т. 20, № 6. – С. 4–60.
23. Байкова И.Е., Никитин И.Г. Лекарственное поражение печени // Рус. мед. журн. – 2009. – № 1. – С. 1–4.
24. Watkins P.B., Kaplowitz N., Slattery J.T. et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial // JAMA. – 2006. – Vol. 296, N 1. – P. 87–93.
25. Маевская М.В., Морозова М.А., Ивашкин В.Т. Алгоритм ведения пациентов с алкогольной болезнью печени // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2011. – Т. 21, № 1. – С. 4–10.
26. Маевская М.В. Алкогольная болезнь печени // Клин. перспективы гастроэнтерол. гепатол. – 2001. – № 1. – С. 4–8.
27. Cohen J.A., Kaplan M.M. The SGOT/SGPT ratio--an indicator of alcoholic liver disease // Dig. Dis. Sci. – 1979. – Vol. 24, N 11. – P. 835–838.
28. Chalasani N., Younossi Z., Lavine J.E. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology // Gastroenterology. – 2012. – Vol. 142, N 7. – P. 1592–1609.
29. Драпкина О.М., Смирин В.И., Ивашкин В.Т. Патогенез, лечение и эпидемиология НАЖБП – что нового? Эпидемиология НАЖБП в России // Рус. мед. журн. – 2011. – № 28. – С. 1717–1721.
30. Амельчугова О., Васютин А., Каспаров Э. и др. Неалкогольная жировая болезнь печени у взрослого городского населения России (распространенность и факторы риска) // Врач. – 2010. – № 9. – С. 2–6.
31. Bellentani S., Scaglioni F., Marino M., Bedogni G. Epidemiology of non-alcoholic fatty liver disease // Dig. Dis. – 2010. – Vol. 28, N 1. – P. 155–161.
32. Cales P., Laine F., Boursier J. et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD // J. Hepatol. – 2009. – Vol. 50, N 1. – P. 165–173.
33. Patton H.M., Lavine J.E., van Natta M.L. et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis // Gastroenterology. – 2008. – Vol. 135, N 6. – P. 1961–1971.
34. Полунина Т.Е., Маев И.В. Наследственный гемохроматоз // Consilium Medicum. – 2009. – Т. 11, № 8. – С. 73–76.
35. Самоходская Л.М., Лавров А.В., Ефименко А.Ю. и др. Особенности генетики наследственного гемохроматоза в русской популяции // Мед. генетика. – 2007. – Т. 6, № 1. – С. 32–36.
36. Johnson P.J., Mcfarlane I.G. Meeting report: International Autoimmune Hepatitis Group // Hepatology. – 1993. – Vol. 18, N 4. – P. 998–1005.
37. Vergani D., Alvarez F., Bianchi F.B. et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group // J. Hepatol. – 2004. – Vol. 41, N 4. – P. 677–683.
38. Ozawa Y., Shimizu T., Shishiba Y. Elevation of serum aminotransferase as a sign of multiorgan-disorders in severely emaciated anorexia nervosa // Int. Med. – 1998. – Vol. 37, N 1. – P. 32–39.
39. Spycher C., Zimmermann A., Reichen J. The diagnostic value of liver biopsy // BMC Gastroenterol. – 2001. – Vol. 1, N 10. – P. 12.
40. Sorbi D., Mcgill D.B., Thistle J.L. et al. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities // Am. J. Gastroenterol. – 2000. – Vol. 95, N 11. – P. 3206–3210.
Review
For citations:
Tereshchenko Yu.A., Tereshchenko S.Yu. Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(1):29-38. (In Russ.)
Views:
93
Email this article 
